Show
Sort by
-
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma
-
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
-
- Journal Article
- A1
- open access
11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma
-
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition
-
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
-
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients
-
- Conference Paper
- C3
- open access
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
-
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets
-
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients
-
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients
-
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
-
- Journal Article
- A1
- open access
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
-
Targeted analysis of TP53 pathway SNPs in neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups
-
- Journal Article
- A1
- open access
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
Identifying and validating DNA methylation biomarkers: the example of neuroblastoma
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
-
- Journal Article
- A1
- open access
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes
-
- Journal Article
- A1
- open access
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.
-
Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma
-
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
-
Identification of a new rare recurrent 1q42.2-qter deletion in neuroblastoma
-
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
-
A multilocus technique for risk evaluation of patients with neuroblastoma
-
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
-
Prognostic impact of gene expression-based classification for neuroblastoma
-
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
-
High throughput stem-loop RT-PCR miRNA expression profiling using minute amounts of input RNA reveals new insights in neuroblastoma pathogenesis